All News

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

OBGYN.net Conference CoverageFrom the American Society of Reproductive Medicine, Orlando, Florida, October 22-24, 2001

The DeLee device has been around for more than 30 years, and with it the theory that mechanical suction at delivery can help prevent MAS. The latest evidence paints a different picture.

A recent study suggests it may not be. Our analysis puts the new data into context and provides clinicians with the practical implications.

When a physician is pulled into a patient's care at the tail end of her management, the repercussions can be negative for both patient and doctor. The patient may suffer because the physician is ignorant of prior diagnoses and treatment, and the doctor may face legal repercussions of being drawn into a situation already gone awry.

A recent study in Obstetrics & Gynecology (06/2006) looked at how practice patterns have changed among Washington state obstetric providers from 2002 to 2004-including how liability issues have affected their practices.

One in eight women of reproductive age has trouble getting pregnant. Knowing what drug treatments are available and how to use them can help you improve patient outcomes.

Ob/gyns are increasingly being called upon to manage subclinical thyroid disease. In this concluding article of a two-part series, two experts clarify the controversy over when to treat mild hyperthyroidism. Do treat a mildly overactive thyroid in elderly patients, they say, because low bone density and cardiac abnormalities can do substantial harm.

Although most cases of mild-to-moderate maternal disease are caused by gestational thrombocytopenia and rarely cause problems, the OB is obliged to rule out more serious causes. And for far-less-common fetal disease, these experts help you differentiate the potentially life-threatening fetal alloimmune thrombocytopenia from a benign drop in platelet count.

We feel it's important to tell patients whose symptoms meet the criteria for migraine whether they have migraine with or without aura.

While fertility treatments have traditionally been aimed at women in their late 30s and 40s, an increasing number of infertility patients are in their 20s, college educated and aware that they are in their prime years to conceive. Many of these young women are reportedly seeking medical help after trying to conceive for just a few months.

A recent report from the Guttmacher Institute has found a "reproductive health gap between poor women and higher-income women." According to the report, unplanned pregnancy rates for poor women have risen 29% since 1994, while the rates for higher-income women dropped 20%-this, despite greater access to contraceptives and legal abortions over the past three decades. Income also seems to have an influence over the timing of abortions: Lower-income women take up to 3 weeks longer than higher-income women to obtain an abortion-a delay that could put poorer women at greater risk.

It seems so according to a report from tje office of U.S. Rep. Henry Waxman, D-Calif. The report notes that crisis pregnancy centers that are federally funded receive monies funneled through the abstinence-only-until-marriage program. It also found that 87% of these centers provided "false and misleading information about the physical and mental health effects of abortion and exaggerated the medical risks of abortion," reported the American College of Obstetricians and Gynecologists government relations newsletter Inside Scoop (07/21/2006).

Long-term treatment with conjugated equine estrogens (CEE) does not increase the risk of breast cancer in postmenopausal women who have had a prior hysterectomy, but it may increase the likelihood that mammographic screening results would require short-interval follow-up, according to the latest data from the Women's Health Initiative Estrogen-Alone trial.

Prophylactic salpingo-oophorectomy has been widely recommended for women with BRCA1 or BRCA2 mutations based on evidence from retrospective studies that have found a strong protective effect against cancers of the ovary and fallopian tube. Now a new international prospective study that included approximately 1,800 women with germline BRCA1 or 2 mutations has found the procedure reduces the overall risk of ovarian, tubal and peritoneal cancers by 80%.

Oral vitamin K (phytonadione and menaquinone-4) is associated with increased bone mineral density and reduced fracture incidence of up to 80% for hip fractures, according to a meta-analysis. Pooling the results of seven trials with fracture outcomes, researchers calculated an odds ratio favoring menaquinone of 0.40 (95% CI; 0.25–0.65) for vertebral fractures, 0.23 (95% CI; 0.12–0.47) for hip fractures, and 0.19 (95% CI; 0.11–0.35) for all nonvertebral fractures.

Which may explain why results of studies to determine whether ginger relieves nausea and vomiting have been inconsistent.

The amount of ionizing radiation conferred by an ordinary chest x-ray significantly increases the already high risk of breast cancer in young women with BRCA1/2 germline mutations, according to a recent international retrospective cohort study.